Tung N, Arun B, Hacker MR, Hofstatter E, et al. TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus
Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast
Cancer (the INFORM trial). J Clin Oncol 2020 Feb 25:JCO1903292. doi: 10.1200/JCO.19.03292.
PMID: 32097092